“By uniting ProductLife Group (PLG)’s regulatory depth with Recipharm’s robust development and manufacturing infrastructure, clients gain a streamlined pathway from early development through to submission and launch,” they state.

“This partnership brings together Recipharm’s development and manufacturing expertise, with PLG’s 2,000 regulatory experts, operating across 150 countries. By integrating scientific, regulatory, operational and commercial strategy from the outset we help our customers move faster, avoid costly delays and build confidence that their product submissions will meet and exceed, agency requirements, for critical medicines worldwide,” says Greg Behar, Recipharm’s CEO.